Edity Therapeutics
Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients. Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins including gene editors, immune sensors, enzymes and intrabodies.
0
0
0
Key Info
- 2020 Founded
- Merkaz, Israel
- 20 Employees
- •••••••••
Credibility
LinkedIn Verified
News
There are no recent news for this organization.
Activity Timeline
There is no recent activity for this organization.
Team
Investments
There is no investment data on this organization.